2021 annual financial data
Supernus Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was 14.84%.
Operating income was 86,029,000 USD and net income was 53,424,000 USD.
Operating cash flow was 127,127,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 579,775,000 USD
- Operating income
- 86,029,000 USD
- Net income
- 53,424,000 USD
- Operating cash flow
- 127,127,000 USD